Giovanni Merlino/LinkedIn
Nov 15, 2026, 15:36
Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
Giovanni Merlino, Head of the SOSD Stroke Unit at the University of Udine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Neurological Sciences, adding:
“After atherosclerotic stroke, recurrence risk peaks early.
LDL-C lowering should too: we started inclisiran in the stroke unit.”
Title: In-hospital inclisiran for early LDL-C lowering after atherosclerotic ischemic stroke: an observational pilot study
Authors: Giovanni Merlino, Roberto Sperotto, Francesco Toraldo, Roberto Marinig, Francesco Janes, Simone Lorenzut, Fedra Kuris, Lorenzo Nesi, Yan Tereshko, Francesco Bax, Carolina Gentile, Gian Luigi Gigli, Mariarosaria Valente
Other posts feauturing Giovanni Merlino on Hemostatis Today.
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice
-
Nov 15, 2026, 15:03Francesco Antonio Veneziano: Rethinking Coronary Artery Disease Through Precision Cardiology
-
Nov 15, 2026, 14:37Denise Rezende: 100 Years of von Willebrand Disease and Advances in Diagnosis
-
Nov 15, 2026, 14:22Ahmed Alotaibi: Does Donor Sex Influence Platelet Storage Quality
-
Nov 15, 2026, 14:09Stephen Alerhand: Acute Pulmonary Embolism vs Chronic Pulmonary Hypertension
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities